Hikal’s journey of innovation and excellence is reflected through its strategic growth and sustainable operations. Focused on enhancing our technology and manufacturing capabilities, we are expanding our geographic and diversifying our sector foothold.
We are recognised for our commitment to ensuring high-quality services and customer satisfaction as we nurture operational excellence and sustainable practices like green chemistry. Focusing on customer-centric growth, we are expanding our customer base and launching new products supported by HiBEX projects and cost-saving measures. During the year, we witnessed traction in our pharmaceutical portfolio across Japan, Latin America, and the Middle East owing to our innovation proficiency and advanced significantly under our Project Pinnacle initiatives.
At Hikal, innovation and excellence are intertwined, delivering outstanding value and sustaining our industry leadership.
REVENUE
EPS
DIVIDEND PAYOUT RATIO
EBITDA MARGIN
CASH FROM OPERATIONS
NET DEBT TO EQUITY
Amidst the global economic uncertainties during the financial year 2023-24, our commitment to resilience remains absolute.
Hikal is the preferred partner for pharmaceuticals and crop protection companies, providing ‘just the right chemistry’ for customised solutions while maintaining high quality and regulatory standards. We foster long-term relationships with global partners by delivering sustainable solutions across the life science value chain.
Vision
To be the leading global fine chemical company to the Pharmaceutical, Crop Protection and Specialty Chemical Industries.
Mission
To create value through superior, chemical products and operate as a responsible company.
We have five manufacturing sites and a world-class R&T centre that cater to domestic and international markets with offices across USA, Europe, India, and Japan.
Our pharmaceutical division excels in manufacturing APIs and intermediates. As a leading partner for global pharmaceutical companies, we specialise in conventional synthesis, complex chiral chemistry, custom synthesis, and contract research. Our proven ability to scale production from grams to tonnes empowers our partners to deliver life-changing treatments worldwide.
REVENUE
EBIT
EMPLOYEES
PERSONNEL IN R&T AND TECHNICAL SERVICES
CAPACITY
We develop animal health APIs and intermediates for the farm and companion animal segment. We create in-house products and offer contract manufacturing from GMP-compliant facilities. Apart from synthetic products, we are developing capability for high potency at our Research and Technology (R&T) Centre.
ENTRY INTO THE BUSINESS
EXISTING RELATIONSHIPS WITH ANIMAL HEALTH INNOVATORS
ANIMAL HEALTH FOCUSED APIs
REACTOR CAPACITY
DEDICATED R&T RESOURCES
New Animal Health Multipurpose facility commissioned at Panoli, Gujarat (validation of several products is in progress)
Read more
We specialise in delivering cost-effective solutions for the agricultural industry. Leveraging research, technology, and manufacturing capabilities, we provide world-class crop protection products, including insecticides, fungicides, herbicides, biocides, and intermediates.
REVENUE
EBIT
EMPLOYEES
PERSONNEL IN R&T AND TECHNICAL SERVICES
CAPACITY
We have now launched Pinnacle 2.0, with a renewed focus on front-end and operational excellence, enhancing customer interactions and optimising processes for superior value and performance. Our vision is to create a better future with global, sustainable, and innovative fine chemical technology proudly Made in India. With our Project Pinnacle, we stay dedicated to sustainability and innovation, setting new industry benchmarks.
Winning Approach
Leading with
Innovation
Our commitment to pioneering solutions is evident in our ongoing investments in Research and Technology (R&T), allocating 4-5% of our sales to R&T for innovative product development.
Elevating Customer
Satisfaction
We prioritise enhancing customer satisfaction across the life sciences value chain through innovative solutions, prompt resolutions, and continuous improvements, fostering strong relationships, loyalty, and a positive brand image.
Maximising
Stakeholder Value
Our focus is on long-term growth, transparency, responsibility, and delivering value to all stakeholders for sustained success.
Aligning with Global
Frameworks and Standards
We emphasise integrating sustainability into our operations, aligning with Global Reporting Initiative (GRI) standards.
At Hikal, we solve complex chemistry problems for global innovators and custom-generic companies through our state-of-the-art Research and Technology Centre. We partner with Pharmaceuticals, Animal Health, Biotech, Crop Protection, and Specialty Chemicals industries to develop sustainable, safe, and cost-effective processes for NCEs, generic molecules, and life-cycle management.
TOTAL EQUITY
NET DEBT
CAPACITY
R&T EXPENDITURE
INVESTMENT IN L&D
OHS TRAINING PROVIDED TO EMPLOYEES
CSR EXPENDITURE
TOTAL ENERGY CONSUMPTION
WATER CONSUMPTION
GHG EMISSIONS PRODUCED
To be the leading global fine chemical company to the Pharmaceutical, Crop Protection and Specialty Chemical Industries.
Distribution
Customers
Research and development
Manufacturing
Just the right chemistry
REVENUE
EBITDA
ADVANCED INTERMEDIATES AND API SOLD
PATENT APPLICATIONS FILED
LTIFR
EMPLOYEE RETENTION RATE
SUPPLIERS ASSESSED ON ESG ISSUES FOR CRITICAL INPUT MATERIALS
LIVES IMPACTED THROUGH CSR ACTIVITIES
REDUCTION IN WATER CONSUMPTION
Delivering consistent shareholder value through our ability to innovate and grow.
Providing life sciences solutions for customers around the world.
Caring and nurturing our employees through an enhanced focus on safety, diversity, and well-being.
Partnering with building strong relationships with our partners.
Driven by empathy to create shared value and empower communities through our CSR activities.
Contributing to societal well-being through integrating sustainability in our operation.
We believe that sustainability is the cornerstone of our long-term success and a vital component in creating value for our stakeholders. By integrating Environmental, Social, and Governance (ESG) principles into our operations, we are committed to making a positive impact on the environment, our employees, and the communities we serve, contributing meaningfully to a more sustainable and equitable future.
Aligned with our vision, we are dedicated to minimising our carbon footprint by adopting sustainable operating processes. We focus on providing green chemistry products, reducing resource dependence, conserving energy, and water, controlling emissions, and minimising waste.
Energy Efficiency and Carbon Emissions
Waste Management 
Water and Effluent Management 
Air Pollution
Biodiversity Protection TOTAL ENERGY CONSUMED FROM RENEWABLE SOURCES (GJ)
YEARLY SAVINGS DUE TO INVESTMENTS IN ENERGY EFFICIENCY
REDUCTION IN WATER CONSUMPTION COMPARED TO 2022-23
INCREASE IN RENEWABLE ENERGY CONSUMPTION COMPARED TO 2022-23
We deeply appreciate the strives of our employees, who have played a vital role in driving Hikal’s future. We nurture a culture of excellence by actively investing in enhancing the skills and capabilities of our workforce to facilitate their personal and professional development.
Diversity, Inclusion, and Equal Opportunities
Employee Well-being, Benefits and Retention 
Employee Training and Development 
Occupational Health and Safety
Human Rights 
Community Development FATALITIES
EMPLOYEE RETENTION RATE
LTI FREQUENCY
FEMALE EMPLOYEES
PERMANENT EMPLOYEES PROVIDED TRAINING ON HUMAN RIGHTS
OHS TRAINING PROVIDED
At Hikal, we recognise the need and significance of good governance in maintaining sustainable and mutually beneficial relationships with all stakeholders. We strictly adhere to the principles of ethics, fairness, and transparency. Our corporate governance structure ensures effective engagement with diverse stakeholders, enabling us to adapt to evolving circumstances.
Risk Management and Business Continuity
Regulatory Compliance 
Product Quality, Safety, and Labelling 
Research and Innovation
Sustainable Supply Chain
Sustainable Financial Performance 
Data Integrity and Security 
Customer Engagement CORRUPTION INCIDENTS REPORTED
WOMEN DIRECTORS
INDEPENDENT BOARD OF DIRECTORS
